Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint Expands Capacity for Genotyping Services Offering

This article has been updated to include the product name for Illumina's genotyping platform.


NEW YORK, Jan. 31 (GenomeWeb News) - DNAPrint Genomics said today that it has expanded the capacity for its genotyping services offering from 1.3 million genotypes per day to more than 3.9 million genotypes per day.


The company has genotyping facilities at headquarters in Sarasota, Fla., as well as at facilities in Richmond, Calif., and Toronto, Canada. The US laboratories use Beckman Coulter's GenomeLab SNPstream genotyping platform, while the Toronto lab uses Illumina's BeadStation.


DNAPrint did not provide details on the additional capacity that it has added for these platforms. Company officials could not be reached for comment.


The company said that the increase in processing capacity will enable it "to process clinical trials samples to ensure that patient population groups are accurately categorized, and perform large-scale genotyping work for the various industries interested."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.